A significant advance in cancer study is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently inactivated in various kinds of cancer, leading https://todaybookmarks.com/story22107646/nanobodies-revive-p53-a-new-approach-for-cancer-treatment